415TiP - ZUMA-3: A phase 1/2 multi-center study evaluation the safety and efficacy of KTE-C19 anti-CD19 CAR T cells in adult patients with relapsed/refractory B precursor acute lymphoblastic leukemia (R/R ALL)
| Autor: | Shah, B., Castro, J., Gökbuget, N., Kersten, M. José, Hagenbeek, T., Wierda, W., Schiller, G., Bot, A., Rossi, J.M., Jiang, Y., Navale, L., Stout, S., Aycock, J., Wiezorek, J., Jain, R. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi135-vi135 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|